MELISSA ZOOK: Open Payments
NPI 1467437293 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 28 payments from 6 companies in 2025. Trend: 2023 $336 · 2024 $304 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $145 |
| Indivior Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $35 |
| PFIZER INC. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, SUBLOCADE, NURTEC ODT, CAPLYTA, Ozempic, Rybelsus, MOUNJARO, UBRELVY.
Industry payments across KY — which companies pay providers there.
